Sanofi, Novavax to Co-Commercialize COVID-19 Vaccine
In an effort to continue expanding on its vaccine development portfolio, Sanofi will be entering into a co-exclusive licensing deal with Novavax.1 Per the agreement, Sanofi will own a co-exclusive license to co-commercialize Novavax’s current stand-alone …